OpenAI has acquired Orchestra Bio to integrate its artificial intelligence technology into the coordination of drug development, with the aim of facilitating scientific work and accelerating the transition from discoveries to approved treatments. #InteligenciaArtificial #DesarrolloDeMedicamentos #Biotecnología (translated)
www.20minutos.es
OpenAI compra Orchestra Bio para llevar sus agentes de IA al desarrollo de medicamentos
